(Q42436184)

English

Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent.

scientific article published on 16 March 2013

Statements

Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit